GO2 For Lung Cancer
Income Statement
Fiscal Year Start:
Jan 1
Data visualization unavailable
Revenues in 2024
$12,221,359
Contributions
N/A
Fundraising Events
N/A
Investments
N/A
Program Services
N/A
Government Grants
N/A
Membership Dues
N/A
Expenses in 2024
$16,930,965
Salaries & Benefits
49%
Advertising & Promotion
13%
Grants
12%
Offices, Occupancy & IT
12%
Other
7%
Fees to Service Providers
6%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$11,105,720
$10,700,361
-4%
Government Grants
$0
$0
-
Fundraising Events
$1,224,873
$1,160,018
-5%
Program Services
$307,690
$202,402
-34%
Membership Dues
$0
$0
-
Investments
$547,038
$513,025
-6%
Other
-$381,263
-$354,447
-7%
Total Revenues
$12,804,058
$12,221,359
-5%
Expenses
2023
2024
Change
Grants
$918,473
$2,019,044
+120%
Benefits to Members
$0
$0
-
Salaries & Benefits
$6,936,269
$8,280,713
+19%
Fees to Service Providers
$1,174,167
$936,679
-20%
Advertising & Promotion
$1,880,781
$2,269,280
+21%
Offices, Occupancy & IT
$1,634,085
$2,013,998
+23%
Interest
$0
$0
-
Depreciation
$134,305
$154,212
+15%
Other
$1,118,905
$1,257,039
+12%
Total Expenses
$13,796,985
$16,930,965
+23%
Net income
2023
2024
Change
Net income
-$992,927
-$4,709,606
-374%
Functional Expenses
Summary
2023
2024
Change
Program
$10,969,624
$13,823,908
+26%
Admin
$975,774
$973,583
0%
Fundraising
$1,851,587
$2,133,474
+15%
Total Expenses
$13,796,985
$16,930,965
+23%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)